Multiple lines of evidence indicate that SDF-1α promotes proliferation and survival of tumour cells in ovarian cancer [48], prostate cancer [49], acute myeloid leukaemia [46], and GBM [15]. This evidence concerns the gene CXCL12 and ovarian carcinoma.